Premium
Inhibition of Superoxide (O 2 − ) in the Paraventricular Nucleus (PVN) Blunts Angiotensin II (Ang II)‐Induced Elevations in Blood Pressure
Author(s) -
Northcott Carrie A,
Haywood Joseph R
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.21.6.a892-b
Circulating Ang II stimulates neural pathways and increases mean arterial pressure (MAP). Moreover, Ang II increases PVN localized O 2 − . Thus, we hypothesized inhibition of O 2 − in the PVN would blunt Ang II‐induced elevations of MAP. Male Sprague Dawley rats were instrumented with venous catheters for delivery of Ang II (30 ng/kg/min, 15ul/min IV, 1 hour) or saline and arterial catheters for MAP measures. Bilateral cannulae in the PVN were used for microinjections of O 2 − scavenger tiron (10 nmol/L, 100 nl/site) or artificial cerebrospinal fluid (aCSF) in conscious rats ten minutes prior to Ang II or saline infusion. To check cannulae placement bicuculline (150 nmol/L, 50 nl/site) was microinjected into the PVN. Pretreatment with tiron significantly blunted Ang II‐induced increases in MAP [Δin MAP; Tiron/Ang II: 30±4 mm Hg vs. aCSF/Ang II: 50±3 mm Hg). Tiron nor aCSF had altered MAP in saline‐infused rats. No changes in heart rate (HR) were observed. Bicuculine induced a significant increase in MAP and HR (Pre‐injection: 83±5 mm Hg, 368±19 bpm vs. Post‐injection: 100±5 mm Hg, 458±13 bpm), indicating PVN placement of cannulae. These data demonstrate that O 2 − in the PVN plays an important physiological role in Ang II‐induced elevations of MAP. In conclusion, elevations in O 2 − in the PVN may contribute to increased excitatory neurotransmitter activity and hypertension.